IP Library Granted Patent US 8,801,593
Granted Patent B2
US 8,801,593 · App. 13/746,996 · Granted Aug 12, 2014

Method of treating anal incontinence

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,801,593
App. No.
13/746,996
Granted
Aug 12, 2014
Kind
B2
Abstract

A method for treating anal incontinence is provided, in which a support member is implanted in a tissue pathway extending from a first location posterior to and adjacent the anus, through the perineum anterior to the anus and terminating at a location posterior to and adjacent the anus opposite the first location.

Claims (31)

1. A method of treating anal incontinence in a patient comprising:

providing an elongate flexible support member having two opposed ends, a flexible tape extending between the two opposed ends, the flexible tape forming a central portion and two elongate extension portions between the two ends;

establishing a pathway in tissue of the patient extending about the patient's anal sphincter and extending into the patient's perineum, comprising the steps of making a left buttock incision in the patient's left buttock at a left pathway end, making a right buttock incision in the patient's right buttock at a right pathway end, making an incision in a posterior vaginal wall that extends into the perineum, establishing a left passage of said pathway extending between said left buttock incision and said vaginal incision, and establishing a right passage of said pathway extending between said right buttock incision and said vaginal incision, wherein said pathway extends from the left pathway end, through the perineum, to the right pathway end; and

implanting the elongate flexible support member in and extending along said pathway to support the anal sphincter.

2. The method of claim 1 wherein said support member extends about the anal sphincter through an included angle of at least 180°, measured about an axis extending centrally through the anus.

3. The method of claim 1 wherein said support member extends about the anal sphincter through an included angle of at least 270°, measured about an axis extending centrally through the anus.

4. The method of claim 1 , wherein:

the step of establishing said left passage comprises passing an elongate surgical instrument between said left buttock incision and said vaginal incision; and

the step of establishing said right passage comprises passing an elongate surgical instrument between said right buttock incision and said vaginal incision.

5. The method of claim 4 , wherein the step of implanting said support member comprises:

securing a first end of said support member to an elongate surgical instrument;

drawing said elongate surgical instrument and said first end of said support member through said left passage; and

securing a second end of said support member to an elongate surgical instrument; and

drawing said elongate surgical instrument and said second end of said support member through said right passage.

6. The method of claim 5 further comprising the step of suturing said support member to the perineal body.

7. The method of claim 1 further comprising the step of tensioning said support member so as to locate said support member in a desired position relative to the anal sphincter.

8. The method of claim 1 wherein said support member is formed of a flexible mesh material.

9. The method of claim 1 further comprising the step of implanting a pelvic organ prolapse device in the patient.

10. The method of claim 1 comprising the step of suturing said support member to the perineal body.

11. The method of claim 1 wherein the central portion extends between an anterior side of the anal sphincter and the posterior vaginal wall.

12. The method of claim 1 wherein the central portion is not positioned to contact vaginal tissue as part of a procedure to treat vaginal prolapse.

13. The method of claim 1 wherein the support member consists of the flexible tape forming a central portion and two elongate extension portions between the two ends.

14. A method of treating anal incontinence in a patient comprising:

forming a first incision in a buttock of the patient posterior to the anus;

forming a second incision in an opposite buttock posterior to the anus;

forming a vaginal incision in the posterior vaginal wall;

forming a tissue pathway between the first and second incisions by passing a surgical instrument between the first incision and the vaginal incision, and between the second incision and the vaginal incision; and

implanting a support member in the tissue pathway such that the support member is positioned around at least 180 of the circumference of the anal sphincter;

wherein the support member comprises two opposed ends, a flexible tape extending between the two opposed ends, the flexible tape forming a central portion and two elongate extension portions between the two ends.

15. The method of claim 14 further comprising the step of suturing said support member to the perineal body.

16. The method of claim 14 wherein the support member consists of the flexible tape forming a central portion and two elongate extension portions between the two ends.

Assignments (10)
RELEASE OF SECURITY INTEREST Recorded Apr 26, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ACTIENT PHARMACEUTICALS LLC; ASTORA WOMEN’S HEALTH HOLDINGS, LLC; ASTORA WOMEN’S HEALTH LLC; AUXILIUM PHARMACEUTICALS, LLC; AUXILIUM US HOLDINGS, LLC; BIOSPECIFICS TECHNOLOGIES CORP.; BIOSPECIFICS TECHNOLOGIES LLC; DAVA INTERNATIONAL, LLC; DAVA PHARMACEUTICALS, LLC; ENDO GENERIC HOLDINGS, INC. (FORMERLY KNOWN AS PAR PHARMACEUTICALS COMPANIES, INC.); ENDO PHARMACEUTICALS INC.; ENDO PHARMACEUTICALS SOLUTIONS INC. (FORMERLY KNOWN AS INDEVUS PHARMACEUTICALS, INC.); GENERICS BIDCO I, LLC; GENERICS INTERNATIONAL (US), INC.; PAR PHARMACEUTICAL, INC.; PAR STERILE PRODUCTS, LLC (FORMERLY KNOWN AS JHP PHARMACEUTICALS, LLC); QUARTZ SPECIALTY PHARMACEUTICALS, LLC; SLATE PHARMACEUTICALS, LLC; VINTAGE PHARMACEUTICALS, LLC
Reel/Frame 067240/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 7, 2017
From: ASTORA WOMEN'S HEALTH, LLC; ENDO HEALTH SOLUTIONS INC.; ASTORA WOMEN'S HEALTH HOLDINGS, LLC
To: BOSTON SCIENTIFIC CORPORATION
Reel/Frame 043778/0302 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 7, 2017
From: BOSTON SCIENTIFIC CORPORATION
To: BOSTON SCIENTIFIC SCIMED, INC.
Reel/Frame 043780/0316 →
SECURITY INTEREST Recorded Jun 8, 2017
From: ASTORA WOMEN'S HEALTH, LLC
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL TRUSTEE
Reel/Frame 042743/0278 →
CORRECTIVE ASSIGNMENT TO CORRECT THE CONVEYING PARTY DATA NAME PREVIOUSLY RECORDED AT REEL: 037300 FRAME: 0728. ASSIGNOR(S) HEREBY CONFIRMS THE CHANGE OF NAME. Recorded Apr 21, 2017
From: AMS RESEARCH CORPORATION
To: AMS RESEARCH, LLC
Reel/Frame 042308/0630 →
CHANGE OF NAME Recorded Jan 18, 2016
From: APHRODITE WOMEN'S HEALTH, LLC
To: ASTORA WOMEN'S HEALTH, LLC
Reel/Frame 037551/0749 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 18, 2016
From: AMS RESEARCH, LLC
To: APHRODITE WOMEN'S HEALTH, LLC
Reel/Frame 037551/0626 →
CHANGE OF NAME Recorded Dec 15, 2015
From: AMS RESEARCH CORPATION
To: AMS RESEARCH, LLC
Reel/Frame 037300/0728 →
RELEASE OF SECURITY INTEREST Recorded Aug 6, 2015
From: DEUTSCHE BANK AG NEW YORK BRANCH
To: AMERICAN MEDICAL SYSTEMS, LLC; AMS RESEARCH, LLC; LASERSCOPE
Reel/Frame 036285/0146 →
GRANT OF SECURITY INTEREST IN PATENTS Recorded Mar 20, 2014
From: ENDO PHARMACEUTICALS SOLUTIONS, INC.; ENDO PHARMACEUTICALS, INC.; AMS RESEARCH CORPORATION; AMERICAN MEDICAL SYSTEMS, INC.; LASERSCOPE
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 032491/0440 →